Manufactured by the Peptide Institute
and Available from Peptides International
Muscarinic Toxins
1) K.N Bradley, Pharmacol. Ther.,
85, 87 (2000).
(Review)
2) L.T. Potter, Life Sci.,
68, 2541
(2001). (Review)
|
CODE |
PRODUCT
|
QTY |
USD |
PMT-4341-s
|
Muscarinic
Toxin 1
(Green Mamba, Dendroaspis angusticeps)
[MTx1, MT1]
Leu-Thr-Cys-Val-Thr-Ser-Lys-Ser-Ile-Phe-Gly-Ile-
Thr-Thr-Glu-Asn-Cys-Pro-Asp-Gly-Gln-Asn-Leu-
Cys-Phe-Lys-Lys-Trp-Tyr-Tyr-Ile-Val-Pro-Arg-
Tyr-Ser-Asp-Ile-Thr-Trp-Gly-Cys-Ala-Ala-Thr-Cys-
Pro-Lys-Pro-Thr-Asn-Val-Arg-Glu-Thr-Ile-Arg-
Cys-Cys-Glu-Thr-Asp-Lys-Cys-Asn-Glu
(Disulfide bond between Cys3-Cys24, Cys17-Cys42,
Cys46-Cys58, and Cys59-Cys64)
(M.W. 7509.6) C326H499N87O101S8
Agonist for Muscarinic Acetylcholine
Receptor-1 (M1)
1) M. Jolkkonen, A. Adem, U. Hellman, C. Wernstedt, and E. Karl,
Toxicon,
33, 399 (1995). (Original-Structure)
2) D. Jerusalinsky and A.L. Harvey,
Trends in Pharmacol. Sci.,
15, 424 (1994).
(Review; Toxin for Muscarinic
Receptors)
3) A. Adem
and E. Karlson, Life Sci.,
60, 1069
(1997). (Pharmacology)
4) H. Nishio,
Y. Nishiuchi, T. Inui, K.N Bradley, A.L. Harvey, and T. Kimura,
Peptide Science 1999, 125 (2000). (S-S
Bond) |
0.1 mg vial |
315 |
| PMT-4340-s |
Muscarinic Toxin 7
(Green Mamba, Dendroaspis angusticeps)
[MTx7, MT7]
Leu-Thr-Cys-Val-Lys-Ser-Asn-Ser-Ile-Trp-Phe-Pro-
Thr-Ser-Glu-Asp-Cys-Pro-Asp-Gly-Gln-Asn-Leu-
Cys-Phe-Lys-Arg-Trp-Gln-Tyr-Ile-Ser-Pro-Arg-Met-
Tyr-Asp-Phe-Thr-Arg-Gly-Cys-Ala-Ala-Thr-Cys-
Pro-Lys-Ala-Glu-Tyr-Arg-Asp-Val-Ile-Asn-Cys-Cys-
Gly-Thr-Asp-Lys-Cys-Asn-Lys
(Disulfide bond between Cys3-Cys24, Cys17-Cys42,
Cys46-Cys57, and Cys58-Cys63)
(M.W. 7472.5) C322H484 N98O96S9
Specific Ligand for Muscarinic
Acetylcholine Receptor-1 (M1)
1) A. Adem and E. Karlson, Life Sci.,
60, 1069
(1997). (Original)
2)
H. Nishio, Y.
Nishiuchi, T. Inui, K.N Bradley, A.L. Harvey, and T. Kimura, Peptide
Science 1999, 125 (2000). (S-S
Bond)
3) J.M. Carsi
and L.T. Potter,
Toxicon,
38, 187 (2000).
(Original; m1-toxin1)
4) Z. Gu,
P.Zhong, and Z. Yan,
J. Biol. Chem.,,
278, 17546
(2003).(
Pharmacology;
Inhibition of
b-Amyloid
Signalling)
|
0.1 mg vial |
315 |
|
PMT-4410-s
|
Muscarinic Toxin
3
(Green
Mamba, Dendroaspis angusticeps)
[MT3,
MTX3, m4-toxin]
Synthetic Product
Leu-Thr-Cys-Val-Thr-Lys-Asn-Thr-Ile-Phe-Gly-Ile-Thr-Thr-Glu-Asn-Cys-Pro-Ala-Gly-Gln-Asn-Leu-Cys-Phe-Lys-Arg-Trp-His-Tyr-
Val-Ile-Pro-Arg-Tyr-Thr-Glu-Ile-Thr-Arg-Gly-Cys-Ala-Ala-Thr-Cys-Pro-Ile-Pro-Glu-Asn-Tyr-Asp-Ser-Ile-His-Cys-Cys-Lys-Thr-Asp-Lys-Cys-Asn-Glu
(Disulfide
bonds between Cys3- Cys24, Cys17- Cys42,
Cys46- Cys57, and Cys58- Cys63)
(M.W.
7379.40 ) C319H489N89O97S8
Specifc Ligand for Muscarinic Acetylcholine
Receptor-4 (M4)
1) M.
Jolkkonen, P.L.M. van Giersbergen, U. Hellman, C. Wernstedt, and E.
Karlsson, FEBS Lett., 352, 91 (1994). (Original; MT3)
2) J.-S. Liang, J. Carsi-Gabrenas, J.L. Krajewski, J.M. McCafferty, S.L.
Purkerson, M.P. Santiago, W.L. Strauss, H.H. Valentine, and L.T. Potter,
Toxicon, 34, 1257 (1996).
(Original; m4-toxin)
3) A. Adem and E. Karlsson,
Life Sci., 60, 1069 (1997). (Pharmacol.; Muscarinic
Receptor Subtype Specificity)
4) S. Katayama, M. Ishimaru, H. Nishio, Y. Nishiuchi, and T. Kimura,
Peptide Science 2004, 161 (2005). (S-S Bond)
|
0.1 mg vial |
315 |
PMT-4424-s
NEW!
|
Muscarinic Toxin
a
(Green Mamba, Dendroaspis angusticeps)
[MTalpha, MTa, MTa]
Leu-Thr-Cys-Val-Thr-Ser-Lys-Ser-Ile-Phe-
Gly-Ile-Thr-Thr-Glu-Asn-Cys-Pro-Asp-Gly-
Gln-Asn-Leu-Cys-Phe-Lys-Lys-Trp-Tyr-Tyr-
Leu-Asn-His-Arg-Tyr-Ser-Asp-Ile-Thr-Trp-
Gly-Cys-Ala-Ala-Thr-Cys-Pro-Lys-Pro-Thr-
Asn-Val-Arg-Glu-Thr-Ile-His-Cys-Cys-Glu-
Thr-Asp-Lys-Cys-Asn-Glu
(Disulfide bond between Cys3-Cys24, Cys17-Cys42,
Cys46-Cys58, and Cys59-Cys64)
(M.W. 7545.4) C326H491N89O102S8
Ligand
for Muscarinic Acetylcholine Receptor-3/5 (M3/M5) (Non-specific Ligand)
1) M. Jolkkonen, P.L.M. van Giersbergen, U. Hellman, C.
Wernstedt, A. Oras, N. Satyapan, A. Adem, and E. Karlsson, Eur. J.
Biochem., 234, 579 (1995). (Original; MTa)
2) A. Adem and E. Karlsson, Life Sci., 60, 1069 (1997). (Pharmacol.;
Muscarinic Receptor Subtype Specificity)
3) M. Jolkkonen, A. Oras, T. Toomela, E. Karlsson, J. Järv, and K.E.O.
Åkerman, Toxicon, 39, 377 (2001). (Pharmacol.;
Mechanism of Receptor Binding)
|
0.1 mg vial |
315 |
|